We are live on ! Find out more
NIP

Nicholas Investment Partners Portfolio holdings

AUM $1.39B
1-Year Est. Return 97.11%
This Fund
S&P 500
This Quarter Est. Return
+8.03%
1 Year Est. Return
+97.11%
3 Year Est. Return
+361.61%
5 Year Est. Return
+496.81%
10 Year Est. Return
+3,647.69%
AUM
$1.09B
AUM Growth
-$31.2M
Cap. Flow
-$172M
Cap. Flow %
-15.81%
Top 10 Hldgs %
22.61%
Holding
250
New
38
Increased
46
Reduced
73
Closed
44

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 22.46%
2 Healthcare 20.78%
3 Technology 19.08%
4 Consumer Staples 8.22%
5 Industrials 5.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVCR icon
26
NovoCure
NVCR
$1.73B
$9.24M 0.85%
146,106
-26,211
-15% -$1.33M
MTDR icon
27
Matador Resources
MTDR
$6.2B
$9.21M 0.84%
463,150
+76,847
+20% +$1.46M
VEEV icon
28
Veeva Systems
VEEV
$33.1B
$8.8M 0.81%
54,257
+60
+0.1% +$8.74K
SMAR
29
DELISTED
Smartsheet Inc.
SMAR
$8.56M 0.79%
+176,874
New +$7.51M
XYZ
30
Block Inc
XYZ
$48.4B
$8.49M 0.78%
117,001
+84,746
+263% +$5.92M
TRNO icon
31
Terreno Realty
TRNO
$7.57B
$8.38M 0.77%
170,825
+43,734
+34% +$1.98M
WMGI
32
DELISTED
Wright Medical Group Inc
WMGI
$8.3M 0.76%
278,322
+75,963
+38% +$2.32M
BAH icon
33
Booz Allen Hamilton
BAH
$8.39B
$8.3M 0.76%
125,310
+29,418
+31% +$1.81M
SRPT icon
34
Sarepta Therapeutics
SRPT
$1.57B
$8.23M 0.75%
54,155
-1,636
-3% -$199K
ARRY
35
DELISTED
Array Biopharma Inc
ARRY
$8.18M 0.75%
176,570
-4,537
-3% -$127K
AMRN
36
Amarin Corp
AMRN
$299M
$8.13M 0.75%
20,973
+7,016
+50% +$2.57M
GH icon
37
Guardant Health
GH
$21.7B
$8.11M 0.74%
+93,916
New +$7.17M
TWNK
38
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
$7.95M 0.73%
550,691
+102,988
+23% +$1.38M
RPD icon
39
Rapid7
RPD
$645M
$7.87M 0.72%
136,005
-20,466
-13% -$1.08M
BURL icon
40
Burlington
BURL
$23.2B
$7.86M 0.72%
46,187
+15,866
+52% +$2.59M
UPLD icon
41
Upland Software
UPLD
$12.8M
$7.63M 0.7%
16,754
+12,022
+254% +$5.5M
EW icon
42
Edwards Lifesciences
EW
$49.6B
$7.63M 0.7%
123,828
+7,332
+6% +$443K
PSNL icon
43
Personalis
PSNL
$1.35B
$7.13M 0.65%
+262,656
New +$7.43M
NVRI icon
44
Enviri
NVRI
$623M
$7.12M 0.65%
259,470
-227,158
-47% -$5.55M
BHVN
45
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$7.12M 0.65%
162,558
+54,516
+50% +$3.07M
APC
46
DELISTED
Anadarko Petroleum
APC
$7.06M 0.65%
+100,000
New +$6.7M
QURE icon
47
uniQure
QURE
$3.03B
$6.82M 0.63%
87,278
-424
-0.5% -$27K
MCHP icon
48
Microchip Technology
MCHP
$40.3B
$6.74M 0.62%
155,568
+35,222
+29% +$1.56M
FISV
49
Fiserv Inc
FISV
$28.8B
$6.63M 0.61%
72,716
+5,875
+9% +$515K
FTDR icon
50
Frontdoor
FTDR
$5.1B
$6.57M 0.6%
+150,924
New +$5.8M

Similar funds

Nicholas Investment Partners's Q2 2019 Portfolio in Review

As of Q2 2019, Nicholas Investment Partners held 250 positions worth $1.09B, down 2.8% from $1.12B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Nicholas Investment Partners withdrew a net $172M in Q2 2019, closing 44 positions and reducing 73 holdings. Its most notable exit was Zuora, Inc., an estimated $26.2M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 22% of assets, down from 25% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Nicholas Investment Partners opened a new position in Essent Group worth $10.3M.

  • Nicholas Investment Partners's largest Q2 2019 buy was Essent Group: 219,020 shares worth $10.3M.
  • Nicholas Investment Partners added most to Pluralsight, Inc. Class A Common Stock in Q2 2019, an estimated $10.4M increase.
  • Nicholas Investment Partners's biggest Q2 2019 reduction was Wynn Resorts, cutting an estimated $24.3M.
  • Nicholas Investment Partners fully exited Zuora, Inc. in Q2 2019, selling an estimated $26.2M.
  • Nicholas Investment Partners's ten largest holdings make up 23% of its $1.09B portfolio in Q2 2019.
  • Nicholas Investment Partners opened 38 new positions and closed 44 in Q2 2019.
  • Nicholas Investment Partners's portfolio value fell 2.8% quarter-over-quarter to $1.09B.

Based on Nicholas Investment Partners's 13F filing for Q2 2019, filed 9 Aug 2019.